Darling Ingredients and its health brand Rousselot have been granted U.S. Patent No. US12636339 by the U.S. Patent and Trademark Office for Nextida GC, a patented collagen peptide ingredient designed to naturally support healthy post-meal blood sugar levels.
The patent protects both the production process and the use of Nextida GC as a dietary supplement ingredient, offering a non-pharmaceutical option for managing blood glucose through science-backed nutrition.
Randall C. Stuewe, Chairman and CEO said, “This patent reinforces the scientific foundation behind Nextida GC and highlights Darling Ingredients’ ability to translate its collagen expertise into targeted health solutions. As demand grows for natural, non-pharmaceutical approaches to health and wellness, we are strengthening our leadership in collagen peptide health ingredients while building a broader pipeline of Nextida solutions.”
Nextida GC is formulated for dietary supplement applications related to natural glucose control and metabolic support. It is part of an expanding portfolio of collagen products being developed to address distinct functional health needs.
So far, Australia, Europe, Japan and China have also awarded patents for Nextida GC, with additional patents pending in Brazil, Canada, Colombia, Korea, Mexico, India and Peru.